Idiopathic pulmonary fibrosis: A disorder of epithelial cell dysfunction

American Journal of the Medical Sciences

Volumn 341, Issue 6, 2011, Pages 435-438

  Zoz, Donald F ^a   Lawson, William E ^a,d   Blackwell, Timothy S ^a,b,c,d  

^a Division of Allergy Pulmonary and Critical Care Medicine   (United States)

^b Department of Cell and Developmental Biology ^*  (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Affairs Medical Center   (United States)

Author keywords

Alveolar epithelial cell; Familial interstitial pneumonia; Idiopathic pulmonary fibrosis; Lung

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; RNA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN C; TELOMERASE REVERSE TRANSCRIPTASE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CONFERENCE PAPER; FIBROSING ALVEOLITIS; GENE MUTATION; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG FIBROBLAST; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; SMOKING;

APOPTOSIS; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MUTATION; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; REGENERATION;

EID: 79958134182     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31821a9d8e     Document Type: Conference Paper

References (38)

1. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-25. (Pubitemid 32758505)
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64.
3. American Thoracic Society/European Respiratory Society. Interna-tional Multidisciplinary Consensus Classification of the Idiopathic In-terstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
4. King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 2005;172:268-79. (Pubitemid 41026138)
5. Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005; 172:1146-52. (Pubitemid 43066651)
6. Thomas AQ, Lane K, Phillips J III, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-8. (Pubitemid 34461748)
7. Thannickal VJ, Toews GB, White ES, et al. Mechanisms of pulmo-nary fibrosis. Annu Rev Med 2004;55:395-417.
8. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 2002;122: 286S-9S. (Pubitemid 36043014)
9. Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features ofsites ofactive extracellular matrix synthesis. Am J Pathol 1991;138:1257-65.
10. Selman M, King TE, Pardo A. Idiopathic pulmonaryfibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-51. (Pubitemid 32096342)
11. Pardo A, Selman M. Molecular mechanisms ofpulmonary fibrosis. Front Biosci 2002;7:d1743-61.
12. Pan LH, Yamauchi K, Uzuki M, et al. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J 2001;17:1220-7. (Pubitemid 32717482)
13. Antoniades HN, Bravo MA, Avila RE, et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990;86:1055-64. (Pubitemid 20370408)
14. Khalil N, O'Connor RN, Flanders KC, et al. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996;14:131-8. (Pubitemid 126441385)
15. Li X, Shu R, Filippatos G, et al. Apoptosis in lung injury and remodeling. J Appl Physiol 2004;97:1535-42. (Pubitemid 39299374)
16. Uhal BD, Joshi I, Hughes WF, et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998;275:L1192-9.
17. Hagimoto N, Kuwano K, Nomoto Y, et al. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 1997;16:91-101. (Pubitemid 127497440)
18. Degryse AL, Tanjore H, Xu XC, et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010;299:L442-52.
19. Wang R, Ibarra-Sunga O, Verlinski L, et al. Abrogation ofbleomy-cin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000;279: L143-51. (Pubitemid 30619534)
20. Kuwano K, Kunitake R, Maeyama T, et al. Attenuation of bleomy-cin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2001;280:L316-25.
21. Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 2004;200:377-89. (Pubitemid 39031256)
22. Sisson TH, Mendez M, Choi K, et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 2010;181:254-63.
23. Nogee LM, Dunbar AE III, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-9. (Pubitemid 32167871)
24. Lawson WE, Crossno PF, Polosukhin VV, et al. Endoplasmic retic-ulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am J Physiol Lung Cell Mol Physiol 2008;294:L1119-26.
25. Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 2009;84:52-9.
26. Mulugeta S, Nguyen V, Russo SJ, et al. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation Am J Respir Cell Mol Biol 2005;32:521-30. (Pubitemid 40770130)
27. Mulugeta S, Maguire JA, Newitt JL, et al. Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4-and cytochrome c-related mechanisms. Am J Physiol Lung Cell Mol Physiol 2007;293: L720-9. (Pubitemid 47358835)
28. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49. (Pubitemid 30408719)
29. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294:L152-60. (Pubitemid 351253350)
30. Chung MP, Monick MM, Hamzeh NY, et al. Role ofrepeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol 2003;29:375-80. (Pubitemid 37093996)
31. Lawson WE, Polosukhin VV, Stathopoulos GT, et al. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol 2005;167:1267-77. (Pubitemid 41541413)
32. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007;356: 1317-26. (Pubitemid 46513297)
33. Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007;104:7552-7. (Pubitemid 47185944)
34. Tanjore H, Xu XC, Polosukhin VV, et al. Contribution ofepithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2009;180:657-65.
35. Lawson WE, Loyd JE. The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease? Proc Am Thorac Soc 2006;3:345-9. (Pubitemid 43845411)
36. Lee HL, Ryu JH, Wittmer MH, et al. Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest 2005;127:2034-41.
37. Lawson WE, Grant SW, Ambrosini V, et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004;59:977-80. (Pubitemid 39490784)
38. Crossno PF, Polosukhin VV, Blackwell TS, et al. Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC Chest 2010;137:969-73.